Deepening mutual trust and jointly pursuing development! Director Zhang Xiaolong of China Resources Henan Pharmaceutical, accompanied by his delegation, paid a visit to Zhongjie Pharmaceutical for an exchange and tour.
2026-04-23
On April 21, with the spring weather mild and the scenery bright, the time was ripe for collaboration. Zhang Xiaolong, Director of the Out-of-Hospital Market Division for the Central and Western Regions at China Resources Henan Pharmaceutical Co., Ltd., led a delegation—including heads of key business units such as the out-of-hospital market, chain‑KA, broad‑market, distribution management, and product management—on a special visit to Henan Zhongjie Pharmaceutical for an exchange. The two sides engaged in comprehensive discussions on critical topics including the deep integration of products and channels, the strategic deployment of key product lines in the out-of-hospital and chain sectors, and innovative cooperation models, laying a solid foundation for the implementation of substantive collaboration and jointly charting a new vision for the synergistic development of the pharmaceutical industry.
On-site visit: Witness the robust capabilities of “Zhongjie Intelligent Manufacturing”
In the morning, accompanied by Yao Yucai, Deputy General Manager of Zhongjie Pharmaceutical’s Marketing System, and key leaders from the sales department, a delegation from China Resources Henan Pharmaceutical visited the solid‑dosage workshop and the smart dispatch center exhibition hall, gaining an up-close understanding of the company’s manufacturing capabilities and quality‑management standards. The group thoroughly examined the end-to‑to‑end quality‑management system, spanning raw‑material receiving, full‑process production control, and finished‑product shipment, and witnessed firsthand the efficient operation of automated production lines and the rigorous, standardized procedures of quality‑assurance testing. The delegation highly commended Zhongjie Pharmaceutical’s achievements in production‑line automation and standardized quality control, as well as its ability to ensure stable supply across nearly 30 product varieties. They expressed particular interest in the company’s core specialty products in areas such as the digestive, cardiovascular, and respiratory systems, engaging in lively discussions on product characteristics and clinical applications.
In-depth discussions and precise matchmaking to jointly explore new avenues of cooperation.
Following the tour, both parties moved to the discussion and exchange area to engage in in-depth dialogue. Yao Yucai, Vice President of Marketing at Zhongjie Pharmaceutical, extended a warm welcome to the visiting delegation and provided a comprehensive overview of the company’s development journey, product pipeline, market coverage, and future strategic plans, with particular emphasis on the R&D capabilities and production‑supply‑guarantee strengths of its core products. Meanwhile, Director Zhang Xiaolong shared China Resources Henan Pharmaceutical’s business footprint across the Central and Western regions, along with the latest developments and resource advantages of each key business segment.
At the symposium, both parties focused on key issues and engaged in precise alignment: for flagship products such as Yilike, Tongguan Teng Oral Liquid, and Baikexing, they discussed entry strategies and sales‑driving plans across retail pharmacy channels, chain KA accounts, and primary‑care settings, aiming to maximize the synergy between product value and channel resources. They proposed an integrated “Product + Academic Support + Sales Promotion” collaboration model, leveraging China Resources’ supply-chain strengths alongside Zhongjie’s portfolio and academic expertise to jointly develop benchmark markets. Both sides reached consensus to launch the first batch of pilot projects centered on China Resources’ Anyang region, implementing targeted promotional campaigns for chain pharmacies and grassroots healthcare outlets, with the goal of scaling up cooperation through a “point‑to‑area” approach.
Complementary strengths, anchoring a new future of mutual benefit.
Director Zhang Xiaolong highly commended Zhongjie Pharmaceutical’s comprehensive strength: “Zhongjie Pharmaceutical boasts a solid manufacturing foundation in Henan, stringent quality control, and a portfolio of highly competitive flagship products, which complement China Resources’ extensive omni-channel reach. We look forward to forging substantive collaborations across the out-of-hospital market, chain‑KAs, and primary healthcare sectors, working together to deliver higher‑quality products and services to end‑users.”
Yao Yucai, Vice President of Marketing at Zhongjie Pharmaceutical, responded positively: “As a regional leader, China Resources Henan Pharmaceutical’s multi-channel synergy and its professional promotion team make it an important strategic partner for us as we deepen our presence at the point of sale. Zhongjie will provide full support—covering product supply, academic assistance, and sales‑driving initiatives—to ensure the collaboration is swiftly implemented and delivers tangible results.”
Pooling strengths and working together to drive high-quality industrial development.
This visit and exchange marks a pivotal starting point for both sides to deepen mutual trust and launch cooperation. Moving forward, the two parties will promptly establish a dedicated coordination mechanism, set up a joint working group, and develop a detailed timeline for advancing the initial batch of cooperative product lines, pilot regions, and sales‑driving strategies. They aim to complete the channel rollout of the first batch of products in the second quarter, ensuring a strong start to their collaboration.
Looking ahead, Henan Zhongjie Pharmaceutical will uphold the philosophy of “quality first, win-win cooperation,” leveraging the robust channel networks and operational expertise of China Resources Henan Pharmaceutical to ensure that high‑quality pharmaceutical products reach end‑users at all levels with maximum efficiency. This will inject momentum into the region’s high‑quality pharmaceutical industry, safeguarding public medication safety and health. Together, we look forward to a promising future!
Henan Zhongjie Pharmaceutical Co., Ltd.
Marketing company
2026.4.21
Real-time news
2026-01-30
Investment Hotline： +86-4001336009
Drug Vigilance Department Contact Hotline：
Address：Xinxiang South Railway Station, Xinxiang City, Henan Province
E-mail：zhongjieyaoye@126.com
Official WeChat
Official Douyin
Copyright © Henan Zhongjie Pharmaceutical Co., Ltd.
Privacy Agreement Supports IPV6 SEO